2020 Q3 Form 10-Q Financial Statement

#000114036120025712 Filed on November 16, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $1.082M $2.396M $2.155M
YoY Change -54.84%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.014M $32.81K $11.65K
YoY Change 2990.12% 228.1% 16.5%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.830K
YoY Change
% of Gross Profit
Operating Expenses $1.407M $2.813M $3.234M
YoY Change -49.97% 28028.21% 32235.32%
Operating Profit
YoY Change
Interest Expense $460.00 $580.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$325.2K -$416.8K -$1.079M
YoY Change -21.98% 4549.21% 9598.1%
Income Tax -$61.01K -$83.78K -$245.6K
% Of Pretax Income
Net Earnings -$264.2K -$333.0K -$833.2K
YoY Change -20.67% 3614.68% 7390.44%
Net Earnings / Revenue -24.42% -13.9% -38.67%
Basic Earnings Per Share
Diluted Earnings Per Share -$440.2K -$665.8K -$228.0K
COMMON SHARES
Basic Shares Outstanding 600.1K 4.859M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.410M $79.07K $91.27K
YoY Change 6741.57% -39.18% -34.81%
Cash & Equivalents $5.410M $5.504M $5.651M
Short-Term Investments
Other Short-Term Assets $200.0K $9.880K $11.83K
YoY Change 1924.29% -1.2% -40.85%
Inventory
Prepaid Expenses $9.875K $11.83K
Receivables
Other Receivables
Total Short-Term Assets $5.759M $88.95K $103.1K
YoY Change 6374.25% -38.98% -35.74%
LONG-TERM ASSETS
Property, Plant & Equipment $35.55K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $160.8K
YoY Change
Total Long-Term Assets $595.5K $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.759M $88.95K $103.1K
Total Long-Term Assets $595.5K $0.00 $0.00
Total Assets $6.354M $88.95K $103.1K
YoY Change 7043.73% -38.98% -35.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $600.5K $18.19K $0.00
YoY Change 3200.83% 8095.05% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $705.9K $18.19K $0.00
YoY Change 3780.12% 8095.05% -100.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $468.1K
YoY Change
Total Long-Term Liabilities $468.1K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $705.9K $18.19K $0.00
Total Long-Term Liabilities $468.1K $0.00 $0.00
Total Liabilities $1.174M $18.19K $0.00
YoY Change 6352.86% 8095.05% -100.0%
SHAREHOLDERS EQUITY
Retained Earnings -$48.71M -$5.915M -$5.883M
YoY Change 723.5% 1.28% 0.88%
Common Stock $6.001K $48.59K $48.59K
YoY Change -87.65% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.180M $4.811M $5.144M
YoY Change
Total Liabilities & Shareholders Equity $6.354M $88.95K $103.1K
YoY Change 7043.73% -38.98% -35.74%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$264.2K -$333.0K -$833.2K
YoY Change -20.67% 3614.68% 7390.44%
Depreciation, Depletion And Amortization $2.830K
YoY Change
Cash From Operating Activities $446.6K -$12.19K -$23.04K
YoY Change -3763.58% 21.9% -53.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 446.6K -12.19K -23.04K
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash 446.6K -12.19K -23.04K
YoY Change -3763.58% 21.9% -117.72%
FREE CASH FLOW
Cash From Operating Activities $446.6K -$12.19K -$23.04K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
600516
CY2019Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
350948
CY2020Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
46850
CY2019Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
53572
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37344
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28435
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53886180
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53886180
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-320438
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-319605
CY2019Q4 us-gaap Assets
Assets
8137156
CY2020Q3 us-gaap Assets
Assets
6354278
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.201
CY2020Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
3205398
CY2020Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
1066230
us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
4549985
CY2019Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
1510674
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6587097
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5409627
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5504275
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1177470
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5826430
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6787097
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11530705
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5609627
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5704275
us-gaap Clearance Fees
ClearanceFees
894375
us-gaap Clearance Fees
ClearanceFees
933620
CY2020Q3 us-gaap Clearance Fees
ClearanceFees
276346
CY2019Q3 us-gaap Clearance Fees
ClearanceFees
329746
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60009005
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
6001
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
6001
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
279981
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2930
CY2020Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
468055
CY2019Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
709663
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
13309
CY2019Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
4436
CY2020Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
4436
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
13309
CY2019Q4 us-gaap Deposits With Clearing Organizations And Others Securities
DepositsWithClearingOrganizationsAndOthersSecurities
200000
CY2020Q3 us-gaap Deposits With Clearing Organizations And Others Securities
DepositsWithClearingOrganizationsAndOthersSecurities
200000
us-gaap Depreciation
Depreciation
8909
us-gaap Depreciation
Depreciation
8345
CY2020Q3 us-gaap Due From Related Parties
DueFromRelatedParties
73584
CY2019Q4 us-gaap Due From Related Parties
DueFromRelatedParties
30625
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
58548
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
985632
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.43
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.02
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.277
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.188
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.212
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-596387
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-83781
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61006
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
-733118
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
526634
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
118936
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
42959
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6722
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
296000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
860830
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
264093
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
922166
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1185638
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2803212
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-416802
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-325186
CY2020Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
399120
CY2019Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
184396
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-328606
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-172945
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-927084
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
789285
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
249568
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
65505
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
217654
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-241608
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-507438
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-10967
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-121064
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
16725
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
0
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6719
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
54808
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
160261
CY2019Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
38483
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
749778
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2729752
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1993131
us-gaap Labor And Related Expense
LaborAndRelatedExpense
6955176
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6354278
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8137156
CY2019Q4 us-gaap Liabilities
Liabilities
2099815
CY2020Q3 us-gaap Liabilities
Liabilities
1173969
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1177470
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2526430
us-gaap Net Income Loss
NetIncomeLoss
-857032
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-333021
us-gaap Net Income Loss
NetIncomeLoss
-2206825
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-264180
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-310398
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-833162
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1040642
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-282454
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3300000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2020Q3 us-gaap Occupancy Net
OccupancyNet
116941
us-gaap Occupancy Net
OccupancyNet
586684
us-gaap Occupancy Net
OccupancyNet
274182
CY2019Q3 us-gaap Occupancy Net
OccupancyNet
193944
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
1407158
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
2812821
us-gaap Operating Expenses
OperatingExpenses
4820475
us-gaap Operating Expenses
OperatingExpenses
9336310
CY2019Q4 us-gaap Other Assets
OtherAssets
281896
CY2020Q3 us-gaap Other Assets
OtherAssets
160832
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
0
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
3300000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44456
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35547
CY2020Q3 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
75568
CY2019Q4 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
808686
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
200000
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
200000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47854840
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48711872
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1066230
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6367360
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2358801
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3570711
CY2019Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
5088
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
13100
CY2020Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
11984
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
15242
us-gaap Revenues
Revenues
3634837
us-gaap Revenues
Revenues
6533098
CY2020Q3 us-gaap Revenues
Revenues
1081972
CY2019Q3 us-gaap Revenues
Revenues
2396019
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5144241
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10318045
CY2020Q2 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
600090
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5180309
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6037341
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
9277403
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5444489
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5754887
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
4811220
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
30488
CY2019Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
4938
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
99115
CY2020Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: #000000; font-weight: bold;">Use of Estimates</div><div><br /></div><div style="text-align: justify; color: #000000;">The Company&#8217;s financial statements are prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that reporting period. Actual results could differ from those estimates.</div></div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
548591
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
600090
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
600090
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
548591
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
mghl Principal Transactions
PrincipalTransactions
7623
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MORGAN GROUP HOLDING CO
dei Entity Central Index Key
EntityCentralIndexKey
0001162283
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
600090
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2019Q4 mghl Deferred Income Tax Assets Net Of Valuation Allowances And Deferred Tax Liability
DeferredIncomeTaxAssetsNetOfValuationAllowancesAndDeferredTaxLiability
2930
CY2020Q3 mghl Deferred Income Tax Assets Net Of Valuation Allowances And Deferred Tax Liability
DeferredIncomeTaxAssetsNetOfValuationAllowancesAndDeferredTaxLiability
0
CY2019Q3 mghl Research Services Fees From Affiliated Entities
ResearchServicesFeesFromAffiliatedEntities
375000
mghl Research Services Fees From Affiliated Entities
ResearchServicesFeesFromAffiliatedEntities
0
CY2020Q3 mghl Research Services Fees From Affiliated Entities
ResearchServicesFeesFromAffiliatedEntities
0
mghl Research Services Fees From Affiliated Entities
ResearchServicesFeesFromAffiliatedEntities
1127500
CY2019Q3 mghl Sales Manager Fees
SalesManagerFees
468189
mghl Sales Manager Fees
SalesManagerFees
590760
CY2020Q3 mghl Sales Manager Fees
SalesManagerFees
0
mghl Sales Manager Fees
SalesManagerFees
334825
mghl Principal Transactions
PrincipalTransactions
5924
CY2020Q3 mghl Principal Transactions
PrincipalTransactions
2961
CY2019Q3 mghl Principal Transactions
PrincipalTransactions
6353
CY2019Q2 mghl Stockholders Equity Return Of Capital
StockholdersEquityReturnOfCapital
3300000
CY2019Q3 mghl Stockholders Equity Return Of Capital
StockholdersEquityReturnOfCapital
3300000
mghl Income Taxes Received From Parent
IncomeTaxesReceivedFromParent
107158
mghl Income Taxes Received From Parent
IncomeTaxesReceivedFromParent
857253
mghl Number Of Nyse Member Firms Through Which All Securities Transactions Are Cleared
NumberOfNYSEMemberFirmsThroughWhichAllSecuritiesTransactionsAreCleared
3
mghl Underwriter Payment Receiving Maximum Period
UnderwriterPaymentReceivingMaximumPeriod
P90D
CY2020Q3 mghl Number Of Shares Issued On Pro Rata Basis
NumberOfSharesIssuedOnProRataBasis
500000

Files In Submission

Name View Source Status
0001140361-20-025712-index-headers.html Edgar Link pending
0001140361-20-025712-index.html Edgar Link pending
0001140361-20-025712.txt Edgar Link pending
0001140361-20-025712-xbrl.zip Edgar Link pending
brhc10017047_10q.htm Edgar Link pending
brhc10017047_ex31-1.htm Edgar Link pending
brhc10017047_ex31-2.htm Edgar Link pending
brhc10017047_ex32-1.htm Edgar Link pending
brhc10017047_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mghl-20200930.xml Edgar Link completed
mghl-20200930.xsd Edgar Link pending
mghl-20200930_cal.xml Edgar Link unprocessable
mghl-20200930_def.xml Edgar Link unprocessable
mghl-20200930_lab.xml Edgar Link unprocessable
mghl-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending